Drug Topics E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
Modern Medicine Network
  Drug Topics E-News
 
January 20, 2010
IN THIS ISSUE
90% rule hits indies
You talkin' for me?
Pipeline drugs 2010
Ohio drug error debated
  TOP SEARCHES: CE // Diabetes // Patient counseling

Independent pharmacies hammered by FSA 90-percent rule
Many independent and small chain pharmacies nationwide are seeing flexible spending account transactions declined, pushing patients out of independent pharmacies and into chains. More....

When pharmacists speak, who listens?
Its very name implies that the American Pharmacists Association would be looking for and advocating solutions to the problems of actual pharmacists, but when it comes to addressing the barriers that stand in the way of our practicing our profession, APhA is nowhere to be found. More...

Pipeline drugs 2010
Categories to watch in this year's diverse drug pipeline include oral agents to treat multiple sclerosis and a host of new diabetes, cardiovascular, and pain-management products. More...

RPh second victim in Ohio drug error
A webinar examining the pharmacy error that led to the death of a two-year-old girl and the conviction of an Ohio pharmacist criticized the legal system for criminalizing the event as well as the flawed hospital procedures that prevented discovery of the pharmacy tech's fatal error. More...


Key Topic Updates
Issues & Trends
 
Professional
 
Clinical
 
Technology
 
Regulatory & Legal

Key Topic Updates

Survey

How many of your patients fill three or more standing prescriptions every month?

1%-15%
 
8%
15%-30%   27%
30%-50%   43%
More than 50% .   22%

This month we would like to know...

How would you rate your level of job satisfaction?

I love my job
I am reasonably satisfied
I am marginally satisfied
It’s a job
I am very frustrated
I am ready to change careers
Click here to vote


Contact Us
Click here to learn more about the Drug Topics editorial team.

Click here to contact the Drug Topics editorial team.

Click here to contact the Drug Topics sales team.

Click here to learn about direct mail, reprints and classifieds in Drug Topics.

Drug Topics Digital Edition
Click here to to view the most recent issue.

Click here to subscribe.

Follow us on Twitter.


You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.